Appropriate Means to Vulgarize the Human Cytogenetics
Zhou Patricia Deh1*, Abou Joël Landry Okon1, Gnaté François Montéomo2, Quidana Désirée Coulibaly1, Mimbra Olivia Annick Bouatinin1, Philippe Irenée Agossou1, Bi You Etienne Bazago Goulai1, Brahima Doukouré3, Gnangoran Victor Yao4, Mohenou Isidore Jean-Marie Diomandé1,3
1Histology-Embryology-Cytogenetics Laboratory, UFR-Medical Sciences, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire.
2Laboratory of Physiology, Pharmacology and Pharmacopoeia, UFR-Nature Sciences, Nangui-Abrogoua University, Abidjan, Côte d’Ivoire.
3Pathological Anatomy and Cytology Laboratory, UFR-Medical Sciences, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire.
4Laboratory of Clinical Cytology and Biology of Reproduction, UFR-Medical Sciences, Alassane Ouattara University, Bouaké, Côte d’Ivoire.
DOI: 10.4236/ojgen.2023.134009   PDF    HTML   XML   83 Downloads   317 Views  

Abstract

Purpose: Insufficient epidemiological data on the prevalence of chromosomal abnormalities may hamper investments in research and interventions for better prevention and treatment of these major threats to the population in numerous countries. The aim of this literature review is to contribute to the popularization of cytogenetics. Methodology: This literature review is a text which contains, analyzes and organizes several referenced articles in French and English which have been selected from electronic databases. It provides a documentation of various activities and progress that have an interest in the field of cytogenetics. Results: In the context of cytogenetics, it is necessary to establish partnerships to strengthen infrastructures and produce quality results. The setting up of cytogenetic services and incentives for participatory research give space to the community in the production of knowledge and innovation, alongside researchers. It’s important to create biobanks, where samples of substances from the human body are collected for use in research into the causes and mechanisms of many diseases and their treatments. To carry out clinical trials aims at assessing the effectiveness of a therapeutic strategy, as is currently the case with the use of cytogenetic tests (karyotype, FISH, etc.) as tool of therapeutic decision and prognostic in cancer biology. The monitoring of the ethic of cytogenetic research projects allows protecting rights, security and welfare of subjects. To solve issues of data management and analysis such as the obstacle to the acquisition of tools and the insufficiency in the training of researchers. Furthermore, dissemination of research results will lead to better understanding of research results, greater public engagement in science and greater social respect for research. Conclusion: Cytogenetics can benefit from these actions such as the development of its research infrastructures and training programs for its workforce as well as the development of its clinical care. All this would have an impact on the population’s state of health.

Share and Cite:

Deh, Z. , Okon, A. , Montéomo, G. , Coulibaly, Q. , Bouatinin, M. , Agossou, P. , Goulai, B. , Doukouré, B. , Yao, G. and Diomandé, M. (2023) Appropriate Means to Vulgarize the Human Cytogenetics. Open Journal of Genetics, 13, 125-133. doi: 10.4236/ojgen.2023.134009.

1. Introduction

Cytogenetics is a discipline that studies genetic material organized in the form of chromosomes. It provides the basic elements on which strategies for clinical or biological diagnosis of chromosomal anomalies, screening, prevention, monitoring and treatment are developed, including genetic counseling for families [1] [2] .

From its origins to the present day, cytogenetics has continued to progress in the analysis of its object of study, the human chromosome.

The first examination to analyze the chromosomes was the karyotype. New molecular cytogenetic technologies were developed which made it possible to identify chromosomal abnormalities down to a size of less than 5 megabases (MB) during the 1980s, then 1990s including fluorescence in situ hybridization (FISH) and the comparative genomic hybridization chip (array-CGH) [3] .

It is well known that chromosomal disorders are a significant cause of premature death or often lifelong disability [4] [5] [6] [7] .

Therefore, the results of literature review conducted in 2022 in Africa found that the proportion of chromosomal disorders among births with congenital anomalies was 8.94% (p < 0.001) [4] . Nevertheless, observations mention an underestimation of epidemiological data in underdeveloped countries mainly linked to the insufficiency of local registry systems and records of real cases [4] [5] [8] [9] [10] . This may hinder investments in research and interventions for prevention and better treatment of chromosomal abnormalities in many countries [4] [7] .

In addition to this, health systems in developing countries are today faced with enormous challenges including the deficiency or absence of prenatal screening, cytogenetic diagnosis and associated services [4] [5] [7] [8] . There are also other factors such as the insufficiency and obsolescence of equipment, lack of qualified human resources and fundings [4] [8] [11] . All these problems therefore prevent the patient to benefit from adequate care and adapted genetic counseling [5] [7] .

In view of the aforementioned difficulties, a question arises. How to improve the quality and quantity of human cytogenetics research?

The objective of this literature review is to contribute to the popularization of cytogenetics from a set of actions that are topical.

2. Methodology

The systematic literature review aims to provide an overview of various current activities and developments that are of interest in the field of human cytogenetics based on relevant literature. Starting from the objective, the investigations focused on several concepts:

- Roles of partnership in research,

- The place of cytogenetic services,

- Contributions of participatory research,

- Roles of biobanks,

- Interests of clinical trials,

- Advantages of monitoring the ethics of research projects,

- Adequate management and analysis of research data,

- And the importance of disseminating research results.

Thus, a documentary search of articles in French and English dating from 2021 to 2023 was undertaken to obtain an idea of all previous notions using electronic databases. The references of 37 selected publications were taken into account.

3. Results

The results of this work have been grouped in a table (Table 1) which displays the contributions of a certain number of current actions whose implementation of which helps to fill existing deficits or allows continued progression in the field of cytogenetics.

4. Discussion

This review identifies a number of current initiatives that would be of benefit to cytogenetics. These are analysed in this work to highlight the relevance of their implementation.

In low- and middle-income countries such as Africa, chromosomal abnormalities are likely to be underestimated due to the lack of accurate data on the causes of death [4] . Chromosomal disorders form a major category of genetic diseases [12] . They have a huge impact on overall health and well-being, causing multiple problems including mental retardation and/or physical disabilities [4] .

However, most African economies allocate only scarce resources to the health research and private investment in this area is also modest. Thus, cooperation with developed countries will make help to strengthen research capacities by obtaining subsidies and producing quality results [13] [14] .

The establishment of efficient and reliable cytogenetic services or laboratories constitutes the places for diagnosis of chromosomal abnormalities [5] . These

Table 1. Set of processes suitable for advancing cytogenetics [5] [12] - [37] .

structures offer tests, including karyotype, fluorescence in situ hybridization (FISH) and comparative genomic hybridization chip (array-CGH) in pre and postnatal. Chromosomal analysis techniques are performed from a variety of samples including amniotic fluid, chorionic villi, peripheral venous blood, bone marrow and lymph nodes [5] [15] [16] .

In addition to previous actions, the development of participatory research is an approach that aims to conduct research by involving the community (associations, families, people with disabilities) and researchers from the study design to the analyze of data. Thus the level of community participation is attracting increasing interest in health science research [17] [18] . For example, associations actively are engaged in biological and clinical research. This commitment takes various forms such as raising awareness of diseases, disseminating knowledge of pathologies and supporting doctoral students. Added to this co-financing of infrastructures and equipments, as well as participation in clinical trials [17] [19] .

It is important to create biobanks that are places of systematic collections of human bodily samples (organs, tissues, blood and cells) as well as DNA as a carrier of genetic material [20] .

The major objective of biobanks is to preserve these resources in optimal conditions in order to maintain their integrity and to make them available to the scientific community in general and in particular to facilitate the search for medicines and innovative diagnostic tests [21] [22] [23] .

In the context of research, a clinical trial is a carefully designed prospective medical study that attempts to accurately answer a set of questions about the effects of a special treatment.

The WHO (World Health Organization) classification of haemopathies has included since 2001 into cytogenetic data [24] . Thus, in oncology, cytogenetic tests such as karyotype and FISH play a key role in diagnosis, prognosis, choice and monitoring of treatment [24] [25] .

Research projects carried out on genetic diseases have made it possible to acquire new knowledge such as genetic testing, genetic counseling, prenatal diagnosis, assisted procreation technologies, embryo manipulation and the constitution of biobanks [23] [26] . They raise multiple ethical issues including the participation of minors in research, incidental findings, the protection of privacy and the interpretation of genetic findings in a personal or family referral. In addition, it is necessary to take into account the right to physical integrity but also the right to decide on the use of personal data [23] [26] [27] . In view of the above observations, it is necessary to emphasize that research protocols in the field of cytogenetics should be examined and approved by the local operational ethics committee.

Moreover, data represents information collected during the conduct of a research project. Their analysis and interpretation is a phase which essentially includes operations of classification, comparison, on each of the information collected in order to find its meaning and to draw conclusions [28] [29] [30] . In the area of research, there is a need for additional support in the management and analysis of large datasets as there seems to be a lack of knowledge about tools and resources for data management. Barriers to acquiring currently available tools are most often related to the financial burdens of small labs and unmet expectations for institutional support [28] [29] [30] .

Institutions should facilitate the training of researchers in management strategies for conducting preserved data themselves, using for example secure networks and data encryption by user authentication through the password [28] [29] [30] .

Dissemination of research is an integral part of the research process. It involves communicating research results to the target community, to decision-makers and others who may benefit from knowledge produced. Research released findings leads to better understanding of findings, increased public engagement in science and greater social respect for research [31] [32] .

There are several ways in which researchers communicate the results of their research. These include writing a book, a journal article or a communication aimed at the general public, and then organizing round tables. Other elements to consider include the creation of websites specific to the research project and the creation of mural or poster for public spaces. A researcher could also associate with others pursuing similar research objectives [32] .

The interest of this study lies in the application of these measures which contribute to the benefits of cytogenetics in Table 1.

At the clinical level, the etiological diagnosis of chromosomal abnormalities makes thus it possible to specify the prognosis and set up appropriate medical follow-up then a systematic screening for complications. Appropriate genetic counseling on the risk of recurrence of the disease can also be established [33] .

In the fields of teaching and research, the acquisition of laboratory materials and equipment allows to offer significant learning experiences to learners in universities and to develop research [34] .

At national level, the above measures would enable the adoption of a prevention policy to limit the risks of spreading chromosomal abnormalities [35] .

It is also desirable, as in some countries, to implement a legal and ethical framework, followed by legislation, for the practice of genetic counseling, pre or postnatal diagnosis. Should be added to previous list clinical trials, the creation of biobanks and prescriptions in the field of cytogenetics, with a view to protecting the rights of subjects, their safety and well-being [23] [26] [36] [37] .

5. Conclusion

Cytogenetics is a clinico-biological discipline that is complemented and perpetuated by new research. Its funding could remain a priority in the government’s economic recovery plan that is the development of its research infrastructures and training programs and for its workforce, as well as the development of its clinical care. This contributes to improving the life expectancy, quality of life and individual well-being.

Author’s Contributions

ZPD collected the data. ZPD, AJLO, GFM, QDC, MOAB, PIA, BYEBG, BD, GVY, MIJMD have contributed to the data analysis.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1] Heng, E., Thanedar, S. and Heng, H.H. (2023) Challenges and Opportunities for Clinical Cytogenetics in the 21st Century. Genes, 14, Article No. 493.
https://doi.org/10.3390/genes14020493
[2] Liehr, T. (2021) Molecular Cytogenetics in the Era of Chromosomics and Cytogenomic Approaches. Frontiers in Genetics, 12, Article ID: 720507.
https://doi.org/10.3389/fgene.2021.720507
[3] Bedei, I., Wolter, A., Weber, A., Signore, F. and Axt-Fliedner, R. (2021) Chances and Challenges of New Genetic Screening Technologies (NIPT) in Prenatal Medicine from a Clinical Perspective: A Narrative Review. Genes (Basel), 12, Article No. 501.
https://doi.org/10.3390/genes12040501
[4] Gebremeskel, A.T. and Seyoum, G.G. (2022) Proportion of Chromosomal Disorders and Their Patterns among Births with Congenital Anomalies in Africa: A Systematic Review and Meta-Analyses. The Scientific World Journal, 2022, Article ID: 6477596.
https://doi.org/10.1155/2022/6477596
[5] Deh, Z.P., Goulai, B.Y.E.B., Montéomo, G.F., Coulibaly, Q.D., Dieth, M.J.A., Okon, A.J.L., et al. (2022) Contribution to the Struggle against Chromosomal Abnormalities from Literature Review. International Journal of Genetics and Genomics, 10, 48-52.
[6] Azonbakin, S., Ouedraogo, A., Ouedraogo, A., Sewadouno, D., Agbanlinsou, A., Goussanou, Y., et al. (2021) Chromosome Polymorphism and Human Pathology: About 27 Cases of Chromosome 9 Inversion in the Beninese Population. Open Journal of Genetics, 11, 23-31.
https://doi.org/10.4236/ojgen.2021.113003
[7] Hosen, M.J., Anwar, S., Taslem, M.J., et al. (2021) Genetic Counseling in the Context of Bangladesh: Current Scenario, Challenges, and a Framework for Genetic Service Implementation. Orphanet Journal of Rare Diseases, 16, Article No. 168.
https://doi.org/10.1186/s13023-021-01804-6
[8] El-Attar, L.M., Bahashwan, A.A., Bakhsh, A.D. and Moshrif, Y.M. (2021) The Prevalence and Patterns of Chromosome Abnormalities in Newborns with Major Congenital Anomalies: A Retrospective Study from Saudi Arabia. Intractable & Rare Diseases Research, 10, 81-87.
https://doi.org/10.5582/irdr.2021.01016
[9] Huber, A.N., Pascoe, S., Fox, M.P., Murphy, J., Phokojoe, M., Gorgens, M., et al. (2023) Leveraging Routine Data in Impact Evaluation: Understanding Data Systems in Primary Healthcare Prior to a Matched Cluster-Randomised Evaluation of Adherence Guidelines in South Africa. South African Medical Journal, 112, 819-827.
https://doi.org/10.7196/SAMJ.2022.v112i10.14909
[10] Malherbe, H.L., Aldous, C., Christianson, A.L., Darlison, M.W. and Modell, B.M. (2021) Epidemiological Data for Selected Congenital Disorders in South Africa. Journal of Community Genetics, 12, 357-376.
https://doi.org/10.1007/s12687-021-00513-8
[11] Koffi, L.B. (2022) La santé publique en Côte d’Ivoire: Un secteur clé de développement en difficulté (1980-1994). International Journal of Humanities and Social Science Invention, 11, 38-44.
[12] Bechar, M.E.A., Guyader, J.M., Bouz, M.E., Douet-Guilbert, N., Falou, A.A. and Troadec, M.B. (2023) Highly Performing Automatic Detection of Structural Chromosomal Abnormalities Using Siamese Architecture. Journal of Molecular Biology, 435, Article ID: 168045.
https://doi.org/10.1016/j.jmb.2023.168045
[13] Zanuso, C., Roudier, P., Chetboun, D., Le Coguic, R., Osman, Y., Dia, D., et al. (2021) Agence française de développement. L’économie africaine 2021. Edition: La Découverte, Collection, Repères, 128 p.
[14] Wenham, C., Wouters, O., Jones, C., et al. (2021) Measuring Health Science Research and Development in Africa: Mapping the Available Data. Health Research Policy and Systems, 19, Article No. 142.
https://doi.org/10.1186/s12961-021-00778-y
[15] Carlotto, B.S., Deconte, D., Diniz, B.L., Silva, P.R.D., Zen, P.R.G. and Silva, A.A.D. (2023) Fluorescence in Situ Hybridization (FISH) as an Irreplaceable Diagnostic Tool for Williams-Beuren Syndrome in Developing Countries: A Literature Review. Revista Paulista de Pediatria, 42, e2022125.
https://doi.org/10.1590/1984-0462/2023/41/2022125
[16] Karim, S., Hussein, I.R., Schulten, H.J., Alsaedi, S., Mirza, Z., Al-Qahtani, M., et al. (2023) Identification of Extremely Rare Pathogenic CNVs by Array CGH in Saudi Children with Developmental Delay, Congenital Malformations, and Intellectual Disability. Children, 10, Article No. 662.
https://doi.org/10.3390/children10040662
[17] Cornish, F., Breton, N., Moreno-Tabarez, U., et al. (2023) Participatory Action Research. Nature Reviews Methods Primers, 3, Article No. 34.
https://doi.org/10.1038/s43586-023-00214-1
[18] Sipari, S., Vänskä, N., Lehtonen, K., Helenius, S., Harra, T., Kinnunen, A., et al. (2023) Participatory Research Partnership in Rehabilitation Co-Development of a Model for Collaboration Process. Disabilities, 3, 410-425.
https://doi.org/10.3390/disabilities3030027
[19] Duea, S.R., Zimmerman, E.B., Vaughn, L.M., Dias, S. and Harris, J. (2022) A Guide to Selecting Participatory Research Methods Based on Project and Partnership Goals. Journal of Participatory Research Methods, 3, 1-28.
https://doi.org/10.35844/001c.32605
[20] Annaratone, L., De Palma, G., Bonizzi, G., et al. (2021) Basic Principles of Biobanking: From Biological Samples to Precision Medicine for Patients. Virchows Archiv, 479, 233-246.
https://doi.org/10.1007/s00428-021-03151-0
[21] Lewis, J. and Holm, S. (2022) Organoid Biobanking, Autonomy and the Limits of Consent. Bioethics, 36, 742-746.
https://doi.org/10.1111/bioe.13047
[22] Tanaka, K., Kato, I., Dobashi, Y., Imai, J.I., Mikami, T., Kubota, H., et al. (2022) The First Japanese Biobank of Patient-Derived Pediatric Acute Lymphoblastic Leukemia Xenograft Models. Cancer Science, 113, 14-25.
https://doi.org/10.1111/cas.15506
[23] Casati, S., Ellul, B., Mayrhofer, M.T., Lavitrano, M., Caboux, E. and Kozlakidis, Z. (2022) Paediatric Biobanking for Health: The Ethical, Legal and Societal Landscape. Frontiers in Public Health, 10, Article ID: 917615.
https://doi.org/10.3389/fpubh.2022.917615
[24] Arber, D.A., Attilio Orazi, A., Hasserjian, R.P., Borowitz, M.J., Calvo, K.R., Kvasnicka, H.M., et al. (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating Morphologic, Clinical, and Genomic Data. Blood, 140, 1200-1228.
https://doi.org/10.1182/blood.2022015850
[25] Ababneh, O., Za’nouneh, F.J.A., Schinke, C., Thanendrarajan, S., Zangari, M., Shaughnessy, J.D., et al. (2022) The Use and Reporting of Cytogenetics in Phase III Multiple Myeloma Clinical Trials. Blood, 140, 532-533.
https://doi.org/10.1182/blood-2022-158282
[26] Al-Fayyad, I., Al-Tannir, M., Abu-Shaheen, A., et al. (2021) To Disclose, or Not to Disclose? Perspectives of Clinical Genomics Professionals toward Returning Incidental Findings from Genomic Research. BMC Medical Ethics, 22, Article No. 101.
https://doi.org/10.1186/s12910-021-00670-y
[27] Mezinska, S., Gallagher, L., Verbrugge, M., et al. (2021) Ethical Issues in Genomics Research on Neurodevelopmental Disorders: A Critical Interpretive Review. Human Genomics, 15, Article No. 16.
https://doi.org/10.1186/s40246-021-00317-4
[28] Falahat, M., Cheah, P.K., Jayabalan, J., Lee, C.M.J. and Kai, S.B. (2023) Big Data Analytics Capability Ecosystem Model for SMEs. Sustainability, 15, Article No. 360.
https://doi.org/10.3390/su15010360
[29] Birkbeck, G., Nagleand, T. and Sammon, D.J. (2022) Challenges in Research Data Management Practices: A Literature Analysis. Journal of Decision Systems, 31, 53-67.
https://doi.org/10.1080/12460125.2022.2074653
[30] Thuermer, G., Guardia, E.G., Reeves, N., Corcho, O. and Simperl, E. (2023) Data Management Documentation in Citizen Science Projects: Bringing Formalisation and Transparency Together. Citizen Science: Theory and Practice, 8, Article No. 25.
https://doi.org/10.5334/cstp.538
[31] Perra, M. and Brinkman, T. (2021) Seeing Science: Using Graphics to Communicate Research. Ecosphere, 12, e03786.
https://doi.org/10.1002/ecs2.3786
[32] Borowiec, B.G. (2023) Ten Simple Rules for Scientists Engaging in Science Communication. PLOS Computational Biology, 19, e1011251.
https://doi.org/10.1371/journal.pcbi.1011251
[33] Turbitt, E., Jacobs, C. and McEwen, A. (2023) Special Issue: Genetic Counseling and Genetic Testing in Precision Medicine. Journal of Personalized Medicine, 13, Article No. 1192.
https://doi.org/10.3390/jpm13081192
[34] Goldstein, B. and Avasthi, P. (2021) A Guide to Setting up and Managing a Lab at a Research-Intensive Institution. BMC Proceedings, 15, Article No. 8.
https://doi.org/10.1186/s12919-021-00214-7
[35] Mijumbi-Deve, R., Parkhurst, J., Jones, C., Juma, P.A., Sobngwi-Tambekou, J.L. and Wenham, C. (2021) Beyond the Metrics of Health Research Performance in African Countries. BMJ Global Health, 6, e006019.
https://doi.org/10.1136/bmjgh-2021-006019
[36] Kruse, J., Mueller, R., Aghdassi, A.A., Lerch, M.M. and Salloch, S. (2022) Genetic Testing for Rare Diseases: A Systematic Review of Ethical Aspects. Frontiers in Genetics, 12, Article ID: 701988.
https://doi.org/10.3389/fgene.2021.701988
[37] Grill, K. and Rosén, A. (2021) Healthcare Professionals’ Responsibility for Informing Relatives at Risk of Hereditary Disease. Journal of Medical Ethics, 47, e12.
https://doi.org/10.1136/medethics-2020-106236

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.